Case Conference August 29th 2018
29-Aug-2018, Divisi Ginekologi Onkologi RSCMCase description
Miss. ES, 59 yo, 4310301
Chief complain : Vaginal bleeding since 15 days on May 2018
History:
Initially patient had vaginal bleeding 15 days since on May 2018. Patient had history recurent vaginal bleeding since 6 months, but patient doesn’t get medical treatment. The history of patient is as follows:
· May 2018 :
Patient had vaginal bleeding 15 days since on May 2018, untill 6 pads/days, patient tell that bleeding lot of clot when patient get urinating. Than patient came to RSUD. Siti Khadijah Pekalongan, and perform US exam (no data), said the OBGYN hyperplasia endometrium and underwent curretage on 30 May 2018, with PA result was endometrial cancer poor differentiated, then patient suggest referred to RSCM or RS.Kariadi Semarang.
· June 2018 :
Because the family event patient came to Jakarta, patient had vaginal bleeding as like when patient get treatment RSUD. Pekalongan, patient complain weakness, the patient came to RSUD. Tarakan , said that Hb 6, taking care with giving transfusion, diagnostic with CT Scan whole abdomen, and patient had PA result and perform HTSOB on July 2018 .
CT Scan Whole Abdomen RSUD. Tarakan
Uterus enlargement, visible intra uterine calcifications, no sign of infiltration in the surrounding tissue
~Myoma uteri dd Ca uteri, no infiltration or metastasis at intraabominal
Post Contrast: heterogenous heating appears on the peripher of the uterus
PA result from HTSOB: endometrioid adenocarcinoma grade III, with tumor cells infiltrate more than half the myometrium, both the tubes and ovaries do not contain tumor cells
PA operation results are said to be be malignant, patient referred to RSCM.
· July 2018 :
Patient came to RSCM with no complain, and bring PA results. In RCSM patient did perform review slide, US fetomaternal examination, roentgen thorax, and laboratorium.
And planning MRI Whole Abdomen with contrast with the aim to see enlargement of the KGB.
Review slide 10-08-2018:
Histology according to endometrioid carcinoma grade 3, invasion of the tumor more than half the thickness of the myometrium, cell tumor not found on the surface and cervical stroma
Fetomaternal US Examination (July 24th 2018)
Non visual uterus and both of ovaries (post HTSOB)
Normal vaginal stump. No enlargement of the parailiac KGB. Liver and Renal wnl. No ascites
~ Endometrial cancer (Post HTSOB), no pelvicum abdominal mass is seen
Radiology Thorax (July 23th 2018):
No radiological abnormalities in the heart and lungs, no metastatic nodules in both lungs.
Laboratory result :
Hb 12.9 Ht 40.3 leukosit 5230 trombosit 277.000 SGOT 21 SGPT 31 Ureum 22 Creatinine 0.6 Albumin 4.0 RBG 91 Electrolit: Na 139 K 4.0 Cl 104.5
Marital Status: Patient not married, P0A0
Physical exam
Fully alert
BP 134/76 Pulse 74, Temp 36, RR 20x/min
BW 49kg, BH 151 cm, BMI 21
General condition
Eyes - no pale conjungtiva, no icteric sclera
Lung - Vesicular, no rhales, wheezing
Heart - normal S1S2, no murmur, gallop
Abdomen - Supel, no mass palpable, normal intestinal sound
Extrimity - warm, no edema.
Gynecological status
Inspection: normal vulva and urethra
RT; no abnormal mass, anal mucosa is smooth
Auxilliary examination
PA form curettage at RSUD. Siti Khadijah, May 30th, 2018 :
Adenocarcinoma poored differentiated
Working diagnosis
Carcinoma endometrium with Incomplete surgical staging( subtotal hysterectomy bilateral salphyngoophorectomy)
Plan
MRI Whole Abdomen with contrast
Clinical question
Patients with carcinoma endometrium, intermediate risk, histopathology grade 3 perform hysterectomy bilateral salphingoovorectomy, What the Role of the General OBGYN in managing endometrial carcinoma? And what the next step management ?
Discussions
This patient with results PA from curretage at RSUD. Siti Khadijah Pekalongan, endometrial cancer poor differentiated, and patient came to RSUD. Tarakan due to vaginal bleeding, from CT Scan Whole Abdomen RSUD. Tarakan post contrast has result heterogenous heating appears on the perifer of the uterus. Patient perform by OBGYN subtotal hysterectomy bilateral salphingoovorectomy, PA result endometrioid adenocarcinoma grade III, with tumor cell infiltrate more than the myometrium, both the tubes and ovaries do not contain tumor cells.
This thing might be happen due to :
1. Missed diagnosis : Improper diagnosis, in which diagnosed with PA from curretage endometrial cancer poor differentiated, CT Scan post contrast has look invasion to the perifer of the uterus. This case are actually must get risk determined; this risk including intermediate risk endometrial carcinoma, after obgyn determined risk of endometrial cancer, further management is in accordance with the risk of malignancy.
this can be happen because of :
· Missed interpretation from the examiner
2. Missed management, in which the management of intermediate risk of endometrial carcinoma should be surgical staging with lymphadenectomy.
Endometrial carcinoma stages I and Occult II: Patients requiring surgical staging |
1. Patients with grade 3 lesions |
2. Patients with grade 2 tumours > 2 cm in diameter |
3. Patients with clear cell or serous carcinomas |
4. Patients with greater than 50% of myometrial invasion |
5. Patients with cervical extension |
Berek and Hackers Gynaecology, 6th, 2015.
CONCLUSSION
• Diagnosis in endometrial carcinoma from histopathology, before managing this problem, this case are actually must get risk determined; this risk including low, intermediate and high risk endometrial carcinoma, after obgyn determined risk of endometrial cancer, further management is in accordance with the risk of malignancy.
• If found that risk intermediate or high risk, we should referred to oncology division.
,
,Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013
13-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 13th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
20-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 20th 2013
13-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 113th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
Index News